Pancreatic cancer is the second most common gastrointestinal malignancy and the fourth most common cause of cancer related deaths in the United States. The incidence of pancreatic cancer increases after age 45, making it a significant problem in the geriatric population. Risk factors for pancreatic cancer include chronic pancreatitis, cigarette smoking, diabetes mellitus, and diet. Most patients are diagnosed after they become symptomatic with abdominal pain, jaundice, or weight loss. Surgery remains the mainstay of treatment, but fewer than 20% of cases are resectable at presentation. Chemoradiation is an adjunct to surgery mainly for palliation of metastases. Even in those resectable, the median survival is a dismal 18 months. Besides the need for advances in therapeutic modalities, defining a high risk, asymptomatic population for screening remains a challenge.
KeywordsPancreatic Cancer Acute Pancreatitis Intraductal Papillary Mucinous Neoplasm Islet Cell Tumor Gastric Outlet Obstruction
- 1.American Cancer Society. Cancer facts & figures 2009. Atlanta: American Cancer Society; 2009.Google Scholar
- 2.Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute; 2009.Google Scholar
- 15.Hruban RH, Pitman MB, Klimstra DS, editors. Ductal adenocarcinoma. In: AFIP atlas of tumor pathology. Tumors of the pancreas, Washington, DC: American Registry of Pathology; 2007. pp 111–64.Google Scholar
- 21.Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol. 2004;99:492–501.PubMedCrossRefGoogle Scholar
- 24.Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355–66.PubMedCrossRefGoogle Scholar